METTLER TOLEDO?s new LiquiPhysics™ Excellence range of density meters and refractometers offer reliable measurement of density, specific gravity, refractive index and Brix, HFCS, alcohol concentrations and API degrees/gravity.
METTLER TOLEDO’s new LiquiPhysics Excellence range of density meters and refractometers offer reliable measurement of density, specific gravity, refractive index and Brix, HFCS, alcohol concentrations and API degrees/gravity. The highly flexible, modular concept of the LiquiPhysics range combines density measurement with refracto-, colori- and/or pH-meters, for simultaneous determination of multiple parameters. Numerous options and external measuring cells are available, protecting your investment by allowing simple expansion of systems as and when additional needs arise.
The instruments’ One Click user interface uses shortcut buttons to allow quick, simple and direct access to all routine tasks, and provides clear user information. A smooth and seamless LIMS/SAP integration with METTLER TOLDEO’s LabX PC software ensures complete and secure traceability, helping you to comply with the many regulatory demands facing the pharmaceutical industry. Sophisticated barcode functions quickly and conveniently input sample data, and automatically ensure the right measurement method is always chosen. Comprehensive testing and error detection functions, along with automatic adjustment verifications, offer tight security for consistent, precise results.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.